Results 141 to 150 of about 8,704 (178)

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial

Lancet, The, 2020
Andrew Lotery, Tunde Peto, Geeta Menon   +2 more
exaly  

Renal Function Stratified Dose Comparisons of Eplerenone Versus Placebo in the EMPHASIS-HF Trial

European Journal of Heart Failure, 2019
Bertram Pitt, Faiez Zannad, John Vincent   +2 more
exaly  

Eplerenone

2007
openaire   +1 more source

Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients

Hypertension, 2002
Barbara Roniker
exaly  

Eplerenone

Reactions Weekly
openaire   +2 more sources

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension

American Journal of Hypertension, 2002
Barbara Roniker, Myron H Weinberger, Weinberger Myron H   +2 more
exaly  

Eplerenone/verteporfin

Reactions Weekly, 2022
openaire   +1 more source

Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects

Journal of the American College of Cardiology, 2011
Bertram Pitt, Faiez Zannad, Joel Menard   +2 more
exaly  

History of Hypertension and Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure

Hypertension, 2008
Bertram Pitt, Faiez Zannad, Ali Ahmed
exaly  

A Comparison of the Aldosterone‐blocking Agents Eplerenone and Spironolactone

Clinical Cardiology, 2008
Allan Struthers
exaly